List of Tables
Table 1. Global RSV Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global RSV Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global RSV Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global RSV Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global RSV Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global RSV Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global RSV Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market RSV Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of RSV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of RSV Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of RSV Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of RSV Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global RSV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global RSV Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global RSV Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global RSV Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global RSV Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global RSV Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global RSV Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global RSV Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global RSV Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global RSV Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America RSV Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America RSV Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America RSV Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America RSV Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America RSV Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe RSV Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe RSV Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe RSV Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe RSV Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe RSV Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific RSV Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific RSV Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific RSV Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific RSV Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific RSV Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America RSV Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America RSV Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America RSV Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America RSV Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America RSV Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa RSV Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa RSV Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa RSV Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa RSV Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa RSV Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global RSV Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global RSV Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global RSV Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global RSV Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global RSV Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global RSV Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global RSV Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global RSV Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global RSV Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global RSV Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global RSV Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global RSV Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global RSV Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global RSV Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global RSV Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global RSV Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global RSV Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global RSV Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global RSV Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global RSV Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer RSV Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. GSK RSV Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Moderna Corporation Information
Table 81. Moderna Description and Business Overview
Table 82. Moderna RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Moderna RSV Vaccine Product
Table 84. Moderna Recent Developments/Updates
Table 85. JNJ Corporation Information
Table 86. JNJ Description and Business Overview
Table 87. JNJ RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. JNJ RSV Vaccine Product
Table 89. JNJ Recent Developments/Updates
Table 90. Bavarian Nordic Corporation Information
Table 91. Bavarian Nordic Description and Business Overview
Table 92. Bavarian Nordic RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bavarian Nordic RSV Vaccine Product
Table 94. Bavarian Nordic Recent Developments/Updates
Table 95. Nuance Pharma Corporation Information
Table 96. Nuance Pharma Description and Business Overview
Table 97. Nuance Pharma RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Nuance Pharma RSV Vaccine Product
Table 99. Nuance Pharma Recent Developments/Updates
Table 100. Advaccine Corporation Information
Table 101. Advaccine Description and Business Overview
Table 102. Advaccine RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Advaccine RSV Vaccine Product
Table 104. Advaccine Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. RSV Vaccine Distributors List
Table 108. RSV Vaccine Customers List
Table 109. RSV Vaccine Market Trends
Table 110. RSV Vaccine Market Drivers
Table 111. RSV Vaccine Market Challenges
Table 112. RSV Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of RSV Vaccine
Figure 2. Global RSV Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global RSV Vaccine Market Share by Type in 2023 & 2030
Figure 4. Clinical I Product Picture
Figure 5. Clinical II Product Picture
Figure 6. Clinical III Product Picture
Figure 7. Preclinical Product Picture
Figure 8. Being Developed Product Picture
Figure 9. Global RSV Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global RSV Vaccine Market Share by Application in 2023 & 2030
Figure 11. Elderly Vaccine
Figure 12. Infant Vaccine
Figure 13. Others
Figure 14. Global RSV Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global RSV Vaccine Market Size (2019-2030) & (US$ Million)
Figure 16. Global RSV Vaccine Sales (2019-2030) & (K Units)
Figure 17. Global RSV Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 18. RSV Vaccine Report Years Considered
Figure 19. RSV Vaccine Sales Share by Manufacturers in 2023
Figure 20. Global RSV Vaccine Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest RSV Vaccine Players: Market Share by Revenue in 2023
Figure 22. RSV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global RSV Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America RSV Vaccine Sales Market Share by Country (2019-2030)
Figure 25. North America RSV Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. United States RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe RSV Vaccine Sales Market Share by Country (2019-2030)
Figure 29. Europe RSV Vaccine Revenue Market Share by Country (2019-2030)
Figure 30. Germany RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific RSV Vaccine Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific RSV Vaccine Revenue Market Share by Region (2019-2030)
Figure 37. China RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America RSV Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America RSV Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa RSV Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa RSV Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE RSV Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of RSV Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of RSV Vaccine by Type (2019-2030)
Figure 56. Global RSV Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of RSV Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of RSV Vaccine by Application (2019-2030)
Figure 59. Global RSV Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 60. RSV Vaccine Value Chain
Figure 61. RSV Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed